Skip to content Skip to sidebar Skip to footer

Ovarian Rejuvenation with FORTASC PRP

At Ovagenesis, we understand the emotional challenges faced by women with low ovarian reserve, advanced maternal age, or early menopause. In the past, egg donation was the only option for achieving pregnancy. However, today we offer an innovative approach—FORTASC PRP and Granulocyte Colony Stimulating Factor (G-CSF)—to enhance reproductive potential in women with low ovarian response.

Untitled - 2025-02-25T121853.826
Untitled - 2025-02-25T122052.224

Advantages of the FORTASC PRP & G-CSF Procedure

The secret to the success and exceptional effectiveness of FORTASC PRP & G-CSF lies in the application of the most advanced double centrifugation technology. Using the Magellan® Tru PRP, the process includes a second spin that allows for the more specialized and refined separation of plasma: the PPP (platelet-poor plasma) is removed, while the PRP (platelet-rich plasma) remains. This precise separation ensures a concentration of growth factors that is up to 4-6 times higher than traditional PRP methods.
This technology offers the ability to concentrate platelets up to 14 times greater than the initial concentration, ensuring maximum effectiveness and speed in enhancing the treatment, providing faster and stronger results.

  • Ovarian Regeneration and Function Improvement

    FORTASC PRP stimulates the ovaries for the restoration and regeneration of their tissues, improving egg quality.

  • Improved Endometrial Receptivity

    The use of G-CSF promotes the interaction between the embryo and the endometrium, improving implantation chances and increasing pregnancy rates.

  • Natural Treatment for Menopausal Symptoms

    FORTASC PRP can help reduce menopausal symptoms, offering a natural and safe solution without medication.

  • Minimal Recovery Time

    The process is quick and requires minimal recovery time, allowing women to return immediately to their daily activities.

  • Advanced Technology for Immediate Results

    We use the 4th Generation PRP FORTE II technology and G-CSF for better and faster results, in line with the latest scientific advancements.

  • Safety and Effectiveness

    The procedure is extremely safe, with minimal side effects, and the results are supported by research showing increased pregnancy rates and reduced miscarriage rates.

Are you ready to start your journey?

Whatever your fertility needs, we are here to offer support and guidance every step of the way.

Why Choose Ovagenesis for Your PRP Treatment

Pioneering Technology

We use double centrifugation technology with the Magellan® Tru PRP, achieving growth factor concentrations up to 14 times higher, ensuring fast and effective results in regeneration and restoration.

Pioneering Regenerative Medicine

At Ovagenesis, our innovation in ovarian and endometrial regeneration places us at the forefront of regenerative medicine in Greece, using advanced technologies and participating in clinical studies for better fertility outcomes.

High Success Rates

Thanks to our clinical experience and scientific data foundation, we have achieved exceptional results, offering hope to women facing difficulties in conception.

Personalized Care

Every woman is unique. Our approach is fully personalized and tailored to the needs and health of your reproductive system.

Support and Guidance at Every Stage

From the initial consultation to complete recovery, our team provides continuous support, guidance, and care, ensuring the best possible experience at every step of the process

Expertise and Clinical Experience

We specialize in the application of innovative fertility treatments, providing personalized solutions that meet the specific needs of each patient.

FREQUENTLY ASKED QUESTIONSAbout FORTASC PRP

FORTASC PRP is an advanced treatment derived from fresh whole blood. It contains a mixture of growth factors and cytokines that help regenerate the ovaries and enhance the receptivity of the endometrium, which is crucial for embryo implantation.

Granulocyte Colony Stimulating Factor (G-CSF) is a glycoprotein that boosts the production of white blood cells and stem cells from the bone marrow, improving endometrial receptivity and increasing pregnancy success rates.

The treatment is suitable for:

  • Women under 50 who are experiencing menopause or perimenopause.
  • Women with low ovarian reserve or low AMH levels.
  • Women with premature ovarian insufficiency (POI).

The procedure involves drawing a small amount of blood, which is processed through centrifugation to produce platelet-rich plasma (PRP). G-CSF is used in combination to improve endometrial receptivity.

The FORTASC PRP procedure involves drawing a small amount of blood from the patient, which is then subjected to centrifugation to separate its various components. Using double centrifugation technology, protein-poor plasma (PPP) is removed, leaving platelet-rich plasma with growth factors (PRP), which is used for ovarian regeneration or to enhance embryo implantation. The entire process is minimally invasive and takes about 1 hour, with immediate return to daily activities.

With the use of double centrifugation technology, platelet concentration can be increased by up to 14 times the initial amount, ensuring maximum effectiveness in the treatment.

After the treatment, improvements may be observed in egg quality and the regenerative capacity of the ovaries. Monitoring is done through monthly tests (FSH, AMH, etc.) for 6 months.

Results are typically noticeable 2-3 months after the first treatment.

With FORTASC PRP, we bring new life to your reproductive health, offering you the opportunity for a brighter and more hopeful journey toward motherhood!